Skip to main content
FinSpry Logo
FinSpry
MGNX logo
MGNX
(NASDAQ)
MacroGenics, Inc.
$4.46-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MacroGenics (MGNX) Stock Price & Financial Analysis

MacroGenics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.10 - $4.56
52-Week High$3.88
52-Week Low$1.19
Open$4.18
Volume1.35M
Average Volume (3M)1.23M
Market Cap274.72M
Shares Outstanding63.16M
Price to Sales (P/S)1.80
Price to Book (P/B)4.83
EV/EBITDA-4.84
Revenue (TTM)149.50M
Net Income (TTM)-74.62M
Free Cash Flow (TTM)-82.95M
EPS (TTM)$-1.18
Profit Margin-49.91%
Operating Margin-48.72%
Return on Equity (ROE)-134.23%
Debt to Equity1.92
50-Day MA$3.06
200-Day MA$2.00
52-Week Change85.53%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About MacroGenics

What is the current stock price for MGNX?

As of the latest trading session, MGNX stock trades at $4.35. The 52-week range is $1.19–$3.88, with a day range of $4.10–$4.56.

What is the P/E ratio for MGNX?

The P/E ratio (Price-to-Earnings) for MGNX is shown in the Key Statistics section. This valuation metric helps compare MacroGenics, Inc. to industry peers.

Does MGNX pay dividends?

MacroGenics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MGNX?

Based on 2 analysts, the consensus for MGNX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MGNX?

MacroGenics's market capitalization is $274.7M, classifying it as a micro-cap company. MacroGenics operates in the Healthcare sector within the Biotechnology industry.